Cytomos

Cytomos is a biotechnology company specializing in real-time single cell analysis, utilizing dielectric spectroscopy and consumer microelectronics to provide label-free detection of cell attributes. The company serves large biotech and pharmaceutical firms, offering solutions that streamline cell line development by identifying lead clones and predicting high-producing cell lines earlier in the process. Cytomos operates in the bioprocess development market, focusing on productivity, stability, and speed to patient. Its business model involves partnerships with major biotech and pharma companies, leveraging its technology to enhance bioprocess efficiency and reduce development timelines. The company's platform technology is applicable to both ATMPs and Biologics, providing significant potential for cost-effective biotechnologies and economies of scale.

Keywords: single cell analysis, dielectric spectroscopy, microelectronics, bioprocess development, cell line development, biotechnology, pharma partnerships, label-free detection, productivity, stability.